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Abstract
The development of completely defined, serum-free media is of
importance to the study of the physiology of cultured cells.

In

this study, experiments aimed at developing a completely defined
medium suitable for growth of a human retinoblastoma tumor cell
line (Y-79) in culture were conducted.

Specifically, the ability

of four trace metals to enhance Y-79 cell growth was studied in
serum-free medium.

Addition of either cobalt, copper, chromium or

selenium to a standard, serum-free medium (RPMX-1640) did not
stimulate Y-79 cell growth.
Previous studies of the Y-79 cell line have demonstrated that
addition of apotransferrin (3 ug/ml) to the culture medium enhances
growth of Y-79 cells.

Therefore, the ability of these trace metals

to further stimulate growth in the presence of apotransferrin
enriched medium was examined.

While chromium, copper or cobalt did

not increase cell number, selenium (3x10

-10

molar) did

potentiate cell growth when added to apotransferrin enriched
medium.
cally.

Therefore, selenium and transferrin must act synergistiThe establishment of improved growth conditions for Y-79

cells in synthetic medium should aid in further studies of the
physiology of both malignent and normal retinal cells.
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Introduction
The development of completely defined, serum-free media is
crucial to the successful analysis of the chemical nature of
cultured cells and of the metabolites and products they excrete.
Completely synthetic media are also important in determining the
mechanism of action of certain factors on cultured cells.

In this

study, we investigated the effects of various metal ions on the
growth of Y-79 cells in serum-free culture.

This cell line derives

from a human retinoblastoma tumor established in culture in this
lab over a decade ago.(48)
Our rationale for this work came from the observation that
conditioned media from Y-79 cells could support the growth of other
untransformed retinal tissue which could not easily be grown in
culture otherwise.

Unfortunately, optimum growth of Y-79 cells

required the addition of fetal calf serum to the medium.

The

presence of serum made it extremely difficult to isolate the growth
factor, which we presumed was synthesized by Y-79 cells, enabling
other neuronal tissue to grow in culture.

The task became one of

discovering a completely defined medium which would optimally
support the growth of Y-79 cells and thereby yield conditioned
medium from which we could hope to isolate a true nerve growth
factor.

This purified growth factor might allow us to grow and

examine normal retinal cells in culture.

Also, we hoped that, by

elucidating the growth requirements of transformed retinal cells,
i*e. Y-79 cells, we could more closely approximate the growth needs
of normal retinal tissue and eventually come to a fuller under¬
standing of the normal physiology of the retina.
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Role of Selenium in tissue culture
Work by Ham in Colorado indicated that trace metals play a
major role in enabling cells to grow in culture.

In his efforts to

develop a protein-free medium, he found that Chinese Hamster ovary

_8
and lung lines require 10
optimum growth (22).

-10

M selenium (given as ^SeO^) for

He discovered the cells' need for Selenium

(Se) when he moved his lab to Boulder, Colorado and could not
achieve cell growth with his protein-free medium (F-12) developed
elsewhere (19).

He eventually noticed that adding Se and/or

L-thyroxine restored growth.

Upon assaying the L-thyroxine for its

Se content, present as a contaminant, he discovered that the Se
alone accounted for all the observed stimulation (22).

McKeehan

et al. have also established Se as essential to the growth of
human fetal lung cells in culture at an optimum concentration of
3x10

—8

M (36).

The exact reasons for this Se effect are

uncertain as the essential role of Se in biological systems has
only recently been recognized.
Se, a group VI element under sulfur in the periodic table, was
discovered by Berzalius in 1817, but for many years, few Se
compounds were investigated.

In the 1930's, Se was identified as a

toxin in animals and extensively investigated as the cause of such
animal diseases as "Blind Staggers" and "Alkali Disease" (39).
However, only in the last 20 years has Se been shown to be an
essential nutrient for many animals and bacteria.

In 1957, Se was

identified as the essential substance in Factor 3, an uncharacter¬
ized dietary supplement, which protected rats from severe necrotic
degeneration of the liver (56).

This observation soon led other

researchers to demonstrate Se responsive diseases in over 40

_

'
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species (6,36) including White Muscle Disease in lambs and calves
(44), exudative diathesis in chicks and turkeys (59), and necrotic
liver degeneration in rats and swine (56,9).

However, to date, no

human disease secondary to Se deficiency has been well documented
although Keshan disease, a fatal cardiomyopathy of children
occurring in a region of China where environmental Se levels are
very low, is thought to be related to inadequate Se intake (72).
Also, one case, resulting from prolonged total parenteral
nutrition, has been reported recently (31).

This dearth of people

suffering from Se deficiency may perhaps be explained by the fact
that most people ingest food from several geographic regions and,
therefore, usually have no difficulty in consuming the presumed
daily requirement of 0.75 ueqs (59).
In the last 10 years, advances have been made in the
elucidation of the role of Se in biochemical processes.
enzymes have been found to contain Se.

Several

Stadtman has elucidated

two bacterial selenoenzymes, formate dehydrogenase and glycine
reductase (59), and three other bacterial enzymes, nicotinic acid
hydroxylase, xanthine dehydrogenase, and thiolase have recently
been identified as likely selenoenzymes (60).

In ovine heart and

skeletal muscle, Se is incorporated into a 20,000 MW hemoprotein
very similar in structure to cytochrome C.

This protein is absent

in the tissue of Se deficient animals suffering from White Muscle
Disease (70).

Finally, Se has been discovered to be an integral

component of the enzyme glutathione peroxidase, (glutathione:
hydrogen peroxide oxidoreductase, EC 1.11.1.9), abbreviated GSH-Px,
isolated from many species, including human tissue.
GSH-Px catalyzes the reaction, ROOH + 2GSH —* ROH + GSSG +
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H2O where ROOH can be any of a variety of hydroperoxides and ROH,
its corresponding alcohol.

GSH is reduced glutathione: GSSG is

oxidized glutathione (73).

This enzyme protects cells against

oxidant damage by reducing many different hydroperoxide substrates,
including H2O2, at rates comparable to reduction of H2O2 by
catalase (15).

However, the enzyme is highly specific for GSH as a

donor substrate and it will not catalyze the breakdown of
hydroperoxides in the presence of other physiological hydrogen
donors (60), except for one study indicating substantial reduction
of linoleic acid peroxide

by liver GSH-Px using cysteine and

cysteamine as hydrogen donors (34).
GSH-Px was first reported present in rat and

bovine erythro-

ocytes in 1957 by Mills who noted that it protected erythrocytes
from hemoglobin oxidation and hemolysis (43).

Later, it was found

that erythrocytes could be protected from hemolysis by adding
glucose to the incubation medium.

The presumed mechanism was that

glucose maintained GSH levels (via the hexose monophosphate shunt)
and thus, provided GSH-Px with a reducing substrate (60).

Rotruck

et al. discovered the connection between GSH and Se in 1971 when
they observed that the protection from hemolysis afforded by the
addition of glucose to the incubation medium was markedly decreased
in erythrocytes from Se deficient rats (52).

In 1973, Rotruck

et al. identified GSH-Px as a selenoenzyme (70).
GSH-Px is an enzyme with a MW of about 80,000 although it
varies somewhat from species to species and from tissue to tissue
within the same species (15).

It was first described in

erythrocytes but has since been documented in many other cell
types.

Tissues highest in GSH-Px include liver, phagocytic cells,

.
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and erythrocytes.

Intermediate levels are found in heart, lung,

kidney, adrenal gland, stomach mucosa, pancreas and adipose tissue.
Low levels have been noted in brain, lens, testis, skeletal muscle,
aorta and uterus (15).

The subcellular localization of GSH-Px has

indicated activity in both the cytosol and mitochondrial fractions
where it is thought to protect the outer and inner mitochondrial
membranes respectively from oxidation (15).
Enzyme studies using tissue from several different species
indicate that the molecule is constructed of four identical
subunits (MW=22,000) and contains four gram atoms of Se per mole of
enzyme (46,11,12,60).

It contains no heme, flavin or other metals

as indicated by the gamma spectrum of the irradiated enzyme (12)
and therefore, differs from all other known peroxidases.

Zakowski

et al. have recently shown that Se is present in the active site
of the reduced enzyme in the form of selenocysteine and have
proven, by sequential Edman degradation, that the selenocysteine is
located within the polypeptide chain (73).
The kinetic mechanism of GSH-Px has been described by Ganther
et al. as a series of three bimolecular steps (14,36) where Se
participates in a set of redox reactions at the active site as
follows:

1) The active site selenol(E-SeH) undergoes oxidation

with peroxide to form a selenenic acid (E-Se-OH).

2) The oxidized

form of the enzyme reacts with the first GSH molecule, forming a
mixed selenosulfide (E-Se-SG) and a molecule of H£0.

3) The

selenosulfide linkage is cleaved by a second GSH molecule,
producing oxidized glutathione and restoring the enzyme to the
selenol form.

An analogous set of reactions can be written in

which Se cycles between selenenic (E-Se-OH) and seleninic
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(E-Se-02H) forms.

There is some evidence for the presence of

different oxo-derivatives of Se during catalysis, but none of these
oxidation states has been conclusively identified in the native
molecule (15).
The activity of GSH-Px in vivo depends on the presence of Se.
Animals maintained on Se deficient diets show rapid increases in
enzyme activity when Se is reinstituted into their diets (69).
Investigators working with cultured cells where Se has been found
to be an essential nutrient have speculated that the growth
enhancing action of Se may be due to its incorporation into the
selenoenzyme, GSH-Px (36,18).

More recently, Germain and Arneson

have ascertained that the activity of GSH-Px in cultured mouse
neuroblastoma cells is directly proportional to the concentration
of selenite in the medium below 6x10

—8

concentations above this value (16).

M and levels off at
This concentration is similar

to the optimum concentrations found for growth enhancement in other
tissue culture work (22,2,36).

Thus, the growth enhancing effects

of Se may very well be secondary to its stimulation of GSH-Px
synthesis and/or activity leading to protection of vital cell
components from oxidation.

In fact, requirements for Se in tissue

culture of diploid human fibroblasts have been found to be
quantitatively lower when cells are grown at lower oxygen
concentrations (37).

Also, the inhibitory effects of excess oxygen

are much more severe when cells are marginally deficient in Se than
when adequate amounts are supplied (20).
Role of Transferrin in Tissue Culture
Our lab has also noted recently that apotransferrin, in an
•

•

—8

optimum concentration of 3 ug/ml (3x10 °M), will support the
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growth of Y-79 cells in iron-free and serum-free medium
(RPMI-1640).

This cell line is unusual because no additional

hormones or growth factors are necessary to support growth.

Many

labs have found that transferrin enhances growth in a variety of
serum-free tissue culture systems but most have required at least
insulin (24,4), and usually other growth factors as well, to
sustain the cells in culture (54,41,7,10,24,49,13,55,68,45).
Transferrin is a serum protein, a B globulin, with a
MW=77,000.

It has a single peptide chain with 2 metal binding

sites which in the past were thought to be very similar (23).
However, the current notion of transferrin binding is that the A
site binds most of the iron at physiological pH's and delivers the
iron used by erythrocyte precursors and the placenta.

The B site,

employed only during situations of iron excess, carries iron to the
hepatocytes (Fletcher-Huehns hypothesis) (5).
Very recently, investigators have noted the presence of
specific receptors for transferrin on transformed cells.

Galbraith

et al. examined 18 human cell lines, including 25 transformed
cell lines of malignant and lymphoblastoid origin, for their
ability to bind transferrin.

Less than 5% of normal cells

(peripheral blood mononuclear cells and cultured diploid
fibroblasts) exhibited membrane binding of transferrin whereas over
80% of the transformed cell lines demonstrated specific receptors
for transferrin (13),

Faulk et al. immunohistologically examined

the breast tissue from 59 patients and determined that almost none

(1/37)

of the tissue from normal areas or benign lesions and 72.7%

of the malignant specimens were positive for the presence of a
transferrin receptor (10).

This receptor will bind apotransferrin
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as well as saturated transferrin whereas receptors found on normal
erythrocyte precursors hardly bind apotransferrin, at all.
Receptors with identical specificity have also been found on normal
trophoblast membrane at the maternofetal interface (10).

These

authors conjecture that the trophoblast and the tumor may benefit
from derepression of receptor synthesis for either nutritional
reasons, lymphocyte modulation or escape from immunosurveillance in
a manner similar to the schistosome (13).
The most obvious explanation for the increased binding of
transferrin by transformed and malignant cells is a nutritional
one.

These rapidly growing cells probably have an increased

requirement for the iron complexed with transferrin.

For example,

iron has been shown to be necessary for DNA synthesis and mitosis
in HeLa cell culture (50) as well as cell division in cultured 3T6
cells (54).

Immature leukemic cells from patients with acute

leukemia will take up radioiron whereas leukocytes from healthy
volunteers lack this ability (7).

Iron may also be necessary for

the synthesis of the electron transport chain and/or the synthesis
of enzymes involved in the oxidation and reduction of critical cell
products such as cis-unsaturated fatty acids and nucleic acid
precursors (71).

Interestingly, GSH-Px activity in erythrocytes is

determined by the availability of iron during development in the
bone marrow.

In blood drawn during the induction of iron

deficiency, younger cells had decreased enzyme activity compared to
older cells.

However, as iron deficient animals were refed iron,

younger cells had higher enzyme activity than did older erythro¬
cytes (51).

Therefore, perhaps Y-79 and other cells exhibit

increased growth in the presence of transferrin simply because of

I

I
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their increased iron requirements.
However, the physiological situation is probably more complex,
especially since transferrin enhances Y-79 cell growth in the
apparent absence of iron.

The reports, cited above, indicating

that transferrin is one of a small number of proteins and growth
factors necessary to support the serum-free growth of embryonal
cancer cells, HeLa cells, B lymphocytes, BHK cells and 3T3 cells,
suggest that transferrin may have other important roles in the
physiology of many cells, a role poorly understood at the present
time.

Other facts about transferrin have emerged which support the

concept of a wider importance for this protein.

Besides its growth

stimulating action, transferrin has been noted to have an
antimicrobial action (5) as well as increasing the mitogenic
response to phytohemagglutinin (PHA) in human lymphocytes.

This

enhancement of the PHA effect at 4-5 ug/ml of transferrin could not
be reproduced by free iron salts (FeCl3 at 10-^-10_^M)
(66).

Whatever the mechanism underlying the growth enhancing

effect of transferrin, one is tempted to speculate that its in
vitro action may be similar to its in vivo role since their
effective concentrations are similar.
Transferrin is also known to bind many other metals besides
iron (23,65) and a specific receptor for zinc, bound to
transferrin, has been observed in human lyumphocytes (47).

While

Se is known to bind to alpha2 and beta globulins and especially
beta lipoprotein (6), it has not been shown to bind to transferrin.
However, several investigators have used Se and transferrin in
combination and found that these agents, plus other factors, could
partially or completely replace serum, depending on the cell line

■
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(18,30,29,4,41,44,37).

Guilbert and Iscove noted serum sparing

effects (from 30% to 2.5% fetal calf serum) in haematopoietic cell
cultures grown in medium containing selenite (10”7M), trans¬
ferrin (3.4xlO”^M), albumin and lecithin (18).

Iscove and

Melchors found that murine B lymphocytes grew and matured into IgM
and IgG secreting cells in serum-free culture medium containing
transferrin (10
lipid.

—8

-7

M), Se (10 'M), albumin and soybean

Their data are difficult to interpret because the soybean

lipid used was a crude lecithin preparation (30).

Hutchings and

Sato developed a serum-free medium, that would support HeLa cells,
containing transferrin (5xlO"^M), Se (1.5xlO”®M), as well
as insulin, aldosterone, epidermal growth factor and fibroblast
growth factor (29).

Breitman et al. reported the growth and

differenciation of human promyelocytic cells in a culture medium
containing Se (3x10
(4).

—8

M), transferrin (5x10

—8

M) and insulin

Therefore, we felt it would be of interest to examine the

effects of transferrin and Se, in concert, on our Y-79
retinoblastoma cell line.
Other Trace Metals
Chromium, copper and cobalt are other trace metals known to be
essential in biochemical processes (39).

Chromium is important for

the maintenance of normal glucose tolerance (40) and at least one
group has found it to enhance growth in a Chinese hamster cell line
in a concentration of 10“9M (22).

Copper, essential-for many

oxidative enzymes as well as for the effective utilization of iron,
has also had growth stimulating effects in vitro
(10"7-10"9M) on human diploid fibroblasts and fetal lung
cells (37), on Chinese hamster cell lines (22,27,19), and NCTC
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Clone 929 Strain L cells (13).

It was also present as a

"contaminant" (.05 mg/L) in Takaota's studies on mouse fibroblasts,
HeLa cells, monkey kidney cells, rate ascites hepatoma cells, rat
thymus reticulum cells, and rat liver parenchymal cells (62,20).
Cobalt is an important requirement for the activity of several
enzymes, including ribonucleotide reductase and glutamate mutase,
as well as for Vitamin

dependent processes.

Ham has found it

helpful in tissue culture of Chinese hamster cells at concentrations of 10”^M (22).

All of these metals are known to bind to

transferrin (23) although iron will displace them if present (5).
Therefore, we decided to examine the effects of the trace metals,
copper, cobalt, chromium and selenium on the growth of Y-79 cells
by testing them alone and in the presence of an optimum
concentration of apotransferrin.
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Materials and Methods
Cells and Materials
The Y-79 human retinoblastoma tumor cell line used in these
studies has been in continuous cell culture in our laboratory since
its establishment in 1971 after removal from the eye of a 2-1/2
year old white girl (48).
Components of the medium were obtained as follows:

RPMI-1640

from Flow Laboratories; fetal bovine serum from Gibco; sodium
selenite (Na2Se03) from Alfa Division, Ventron Corporation;
cobalt chloride (CoCl2*6H20) from Fisher; Chromium chloride
(CrCl3*6H20) and copper sulfate (CuSC>4*5H20) from
J.T. Baker.

Bovine albumin (fatty acid free) and Human

Apotransferrin (pfs) were obtained from Sigma.

The antibiotics

penicillin (10,000 u/ml) and streptomycin (10,000 ug/ml) were
purchased as lOOx concentrated solutions in physiological saline
from Grand Island Biological Company.

RPMI-1640 is dissolved in

deionized, doubly distilled water prepared in our laboratory.
Maintenance of Y-79 Cell Culture
The Y-79 stock cell cultures were maintained in RPMI-1640
supplemented with 5% fetal bovine serum, 3xl0~®M Na2Se03,
100 u/ml of penicillin, 100 ug/ml of streptomycin and .01 M HEPES
(N-2-hydroxyethyIpiperazine-N"-2-ethane sulfonic acid).

They were

grown in suspension in 150 ml flasks (Costar) in a total volume of
approximately 75 ml at 37°C in a moist atmosphere of 95% air
and 5% CO2.
needed.

The cultures were fed twice weekly and split as

During feeding, approximately 10 ml of the depleted medium

were left in the flasks.

14

Growth Experiments .
Y-79 cells were spun down in 50 ml centrifuge tubes (Corning)
and washed once in serum-free medium.

They were resuspended by

vigorous pipetting and a 0.5 ml sample was counted by Coulter
Counter (standardized periodically with a hemacytometer count of
cells treated with trypan blue).

Cells were then divided, spun

down in 15 ml centrifuge tubes (Corning), and brought up in the
various experimental media.

(The experimental media consisted of

RPMI-1640, penicillin (100 u/ml), streptomycin (100 ug/ml), HEPES
(.01M) and varying concentrations of cobalt chloride, sodium
selenite, copper sulfate, or chromium chloride, with and without
the addition of 3 ug/ml of apotransferrin as explained in the
results.)

These cells were then divided into 16x125 mm tissue

culture tubes (Corning) in 1 ml aliquots with a projected final
cell concentration of 5x105 cells/ml, and 0.5 ml of the residual
cells in the various media were counted as below to verify cell
number.

The tissue culture tubes were slanted at 5° and

incubated at 37°C in a moist atmosphere of 95% air and 5%
CO2.

Cells were fed on day 4 by the following procedure:

5 ml

of fresh medium were added to each tissue culture tube and the
cells were spun down.

5 ml of medium was then evacuated,

leaving 1

ml of medium into which the pellet was resuspended.
Counting Procedure and Data Analysis
Two tubes were randomly selected for counting on days 1,2,4,
and 7.

1-1/2 hours prior to counting, bovine serum albumin was

added to each sample (1 mg/ml) because this procedure was found to
ensure uniformity of cell size before counting with the Coulter
Counter.

Each 1 ml sample was diluted with isotonic buffered

'
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saline (Scientific Products) and counted twice on the Coulter
Counter and the results corrected and averaged.
deviations were computed for each data point.

Standard
In some cases, data

were represented as a ratio of cell number at day 4 (A) to cell
number at day 1 (B) in order to standardize for differences in
initial cell concentration.

The error of this ratio was computed

via the following formula and the errors averaged.
S(j(A/B) = y 1/B2(var A) + A2/B^(var B)
Day 1, and not day 0, was chosen as the denominator for this ratio
because the counting procedure for day 0 differed from that of day
1 through day 7 in number of samples averaged as well as aliquot
size.

In one instance, noted in the results, the ratio of cell

number at day 3 to cell number at day 1 was used.
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Results
I.
Effect of Trace Metals on Y-79 cell growth in the Absence of
Apotransferrin
In order to determine the effect of the addition of cobalt,
copper, chromium, and selenium ions on the growth of Y-79 cells in
culture, a variety of concentrations of each metal were tested.
Figure 1 illustrates the seven day growth curve of Y-79 cells in
concentrations of C0CI2 ranging from 10-^-10~^M.

In

Figure 2, the ratio of cell number at day 4 to cell number at day 1
is shown.

In comparison to the cells grown in RPMI-1640 without

CoCl2 added, there does not appear to be any enhancement of
growth.

Indeed, at each concentration of C0CI2 tested, growth

lagged behind that of the control cells.

As expected, cells

maintained in medium enriched with 5% fetal bovine serum
outstripped all other groups in growth between day 1 and day 4.
Figure 3 and 4 show comparable results for CUSO4 in
concentrations ranging from 10

-10

M.

There was no

enhancement of Y-79 cell growth when this metal was added to the
medium.
The results found when CrCl3 was added,
10~10-10"7M, are displayed in Figures 5 and

in concentrations of
6.

No signi¬

ficant enhancement of growth was noted at any of the concentrations
tested.

Similarly, at 10”^- 3xlO~^M Na2Se03, growth

increments between day 1 and day 4 did not differ significantly
from controls (Figures 7 and

II.

8).

Effect of Trace Metals on Y-79 Cell growth in The Presence of
Apotransferrin
Consistent with results found previously in our laboratory

(unpublished), the addition of 3 ug/ml of apotransferrin to the

.
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culture medium resulted in a reproducible enhancement of growth.
For example, as illustrated in Figure 10, cells grown in
apotransferrin-enriched medium grew better than control cells.
However, growth of these cells was surpassed by that of cells grown
in medium supplemented with 5% fetal bovine serum.

In order to

determine whether the addition of trace metals could lessen this
discrepency, the effects of cobalt, copper, chromium and selenium
were ascertained in the presence of apotransferrin.
Figure 9 presents the four day growth curves of cells grown in
the presence of

10

^ -

C0CI2 as well as growth

10

curves of control cells grown in either serum-free medium,
serum-free medium plus apotransferrin or serum-enriched medium.
Figure 10 illustrates the ratio of cell number at day 4 to cell
number at day 1.

When this ratio is used as a measure of growth,

it becomes apparent that the addition of C0CI2 does not alter the
enhancement of cell growth rate produced by apotransferrin.
Figures 11 and 12 present comparable data for concentrations
of CUSO4 ranging from

10“^-

10“^M.

Although 10“^M

CUSO4 appears to enhance growth above the level produced by
apotransferrin alone, suggesting that lower concentration of
CUSO4 may enhance growth, additional experiments including
concentrations of CUSO4 as low as

10”^M,

did not support a

consistent growth effect at these lower concentrations.
The effect of CrCl3 is presented in figures 13 and 14.
There, too, it is evident that concentrations of this metal ion
ranging from

10”^®- 10~^M

had no significant effect on

growth of Y-79 cells.
In contrast to the other metals tested, Na2Se(>3, in the
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presence of apotransferrin, clearly enhanced cell growth beyond the
effect produced by apotransferrin alone.

This effect appears at

concentrations of 3xlO”^M Na2SeC>3 and below.

(Figure 16).

In an attempt to define the optimum concentration of Na2SeC>3,
these experiments were repeated in the presence of lower
concentrations of selenium.
10

•*"10

-10

-8

•

The effect appears to plateau at

M selenium and by 10

disappears.

i3

«

M, growth enhancement

1

<
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FIGURE 1
Seven day growth curve of Y-79 cells grown in the presence of
RPMI-1640 + varying concentrations of C0CI2 without the addition
of apotransferrin.

The points designated "0" and "5%" refer to

those cells grown without added C0CI2 or serum and those cells
incubated in medium enriched with 51 fetal bovine serum
respectively.

Cells were fed on day 4.

KEY

0

52

O-—O

10“6M CoC12

O———□

10“7M C0CI2

■-—Hi

10”8M C0CI2

— — — -■

10”9M C0CI2

A—

Cell Nuriber

20

Time (Days)

21
FIGURE 2
Effect of varying concentrations of C0CI2 on cell growth.

The

ratio of cell number at day 4 to cell number at day 1 is used as a
measure of growth.

The effect of RPMI-1640 enriched with 5% fetal

bovine serum is also shown.
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FIGURE 3
Six day growth curve of Y-79 cells grown in the presence of
RPMI-1640 + varying concentrations of CUSO4 without
of apotransferrin.

the addition

The points designated "0" and "52" refer to

those cells grown without

added CUSO4 or serum and those cells

incubated in medium enriched with 52 fetal bovine serum
respectively.

Cells were fed on day 4.
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FIGURE 4
Effect of varying concentrations of C11SO4 on cell growth.

The

ratio of cell number at day 3 to cell number at day 1 is used as a
measure of growth.

The effect of RPMI-1640 enriched with 5% fetal

bovine serum is also shown.
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FIGURE 5
Seven day growth curve of Y-79 cells grown in the presence of
RPMI-1640 + varying concentrations of CrCl3 without the addition
of apotransferrin.

The points designated "0" and "5%" refer to

those cells grown without added CrCl3 or serum and those cells
incubated in medium enriched with 51 fetal bovine serum
respectively.

Cells were fed on day 4.
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FIGURE 6

Effect of varying concentrations of CrCl3 on cell growth.

The

ratio of cell number at day 4 to cell number at day 1 is used as a
measure of growth.
is also shown.

The effect of RPMI-1640 enriched with 5% FBS
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FIGURE 7
Seven day growth curve of Y-79 cells grown, in the presence of
RPMI-1640 + varying concentrations of Na2Se03 without the
addition of apotransferrin.

The points designated "0" and "52"

refer to those cells grown without added Na2Se03 or serum and
those cells incubated in medium enriched with 5% fetal bovine serum
respectively.

Cells were fed on day 4.
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FIGURE 8
Effect of varying concentrations of Na2Se(>3 on cell growth.
The ratio of cell number at day 4 to cell number at day 1 is used
as a measure of growth.

The effect of RPMI-1640 enriched with 51

fetal bovine serum is also shown.
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FIGURE 9
Four day growth curve of Y-79 cells grown in RPMI-1640 + 3 ug/ml of
apotransferrin + varying concentrations of C0CI2.

The points

designated "0" and "52" refer to those cells grown without added
C0CI2, apotransferrin, or serum and those cells incubated in
medium enriched with 5% fetal bovine serum respectively.

"0 + trf"

represents those cells grown in medium containing apotransferrin
but devoid of C0CI2 or serum.
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FIGURE 10
Effect of varying concentrations of C0CI2 on cell growth in the
presence of 3 ug/ml of apotransferrin.

The ratio of cell number

at day 4 to cell number at day 1 is used as a measure of growth.
See figure 9 for an explanation of the symbols, "0", "5%" and "0 +
trf ".
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FIGURE 11
Four day growth curve of Y-79 cells grown in RPMI-1640 + 3 ug/ml of
apotransferrin + varying concentrations of CUSO4.

The points

designated "O" and "5%" refer to those cells grown without added
C0CI2,

apotransferrin,

or serum and those cells

incubated in

medium enriched with 51 fetal bovine serum respectively.
represents

"0

+ trf"

those cells grown in medium containing apotransferrin

but devoid of CUSO4 or serum.
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FIGURE 12
Effect of varying concentrations of C11SO4 on cell growth in the
presence of 3 ug/ml of apotransferrin.

The ratio of cell number at

day 4 to cell number at day 1 is used as a measure of growth.

See

figure 11 for an explanation of the symbols, "0", "5%", and "0 +
trf".
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FIGURE 13
Seven day growth curve of Y-79 cells grown in RPMI-1640 + 3 ug/ml
of apotransferrin + varying concentrations of CrCl3„

The points

designated "0" and "52" refer to those cell6 grown without added
CrCl3, apotransferrin, or serum and those cells incubated in
medium enriched with 52 fetal bovine serum respectively.

"0 + trf"

represents those cells grown in medium containing apotransferrin
but devoid of CrCl3 or serum.

Cells were fed on day A.
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FIGURE 14
Effect of varying concentrations of CrCl.3 on cell growth in the
presence of 3 ug/ml of apotransferrin.

The ratio of cell number at

day 4 to cell number at day 1 is used as a measure of growth.

See

figure 13 for an explanation of the symbols, "0", "5%", and "0 +
trf".
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FIGURE 15
Seven day growth curve of Y-79 cells grown in RPMX-1640 + 3 ug/ml
of apotransferrin (trf) + varying concentrations of Na2SeQ3.
The points designated "0" and "52" refer to those cells grown
without added Na2Se03, trf, or serum and those cells incubated
in medium enriched with 52 fetal bovine serum respectively.

"0 +

trf" represents those cells grown in medium containing trf but
devoid of Na2Se03 or serum.

Cells were fed on day 4.
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FIGURE 16
Effect of varying concentrations of Na2Se03 on cell growth in
the presence of 3 ug/ml of apotransferrin.

The ratio of cell

number at day 4 to cell number at day 1 is used as a measure of
growth.

See figure 15 for an explanation of the symbols, "0",

"5%", and "0 + trf".
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Discussion
These studies indicate that none of the four trace metals,
tested in the absence of trasnferrin, were active in enhancing Y-79
cell growth.

In fact, the cobalt and copper ions, at the

concentrations tested, appeared to be somewhat inhibitory for the
first four days of the experiment.

Perhaps, a trial of lower

amounts of these ions might be justified in light of Ham's use of
10"8M CuS04*5H20 and 10“9M CoC12*6H20 as
optimum concentrations in his protein-free, synthetic medium,
MCDB-301 (22).

The ineffectiveness of the addition of cobalt may

also be secondary to the presence of a minimal amount of vitamin
b12 (0.005 mg/L) in RPMI-1640.

Also, perhaps, the Y-79 cell line

is unable to utilize inorganic cobalt or copper.
The inability of chromium chloride to stimulate growth was not
unexpected in light of present knowledge regarding the role of
chromium in biological systems.

Chromium has been studied

extensively because it has long been known to be necessary for the
maintenance of normal glucose tolerance in animals (31).

However,

chromium is biologically active in the form of an incompletely
characterized group of complexes collectively known as "glucose
tolerance factor".

This factor is thought to operate by complexing

with insulin and its tissue receptor and thereby facilitating
insulin-receptor binding (40,38).

Therefore, it is not surprising

that chromium has never been found to be effective in the absence
of insulin (39).

Perhaps, a trial of chromium in the presence of

insulin may unmask a growth potentiating effect of this metal in
culture of Y-79 cells.
Another difficulty remains, however.

While inorganic chromium
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is an effective dietary supplement for animals, the active form,
the so-called glucose tolerance factor, has never been completely
isolated.

It is thought to contain trivalent chromium complexed

vith nicotinic acid, glutamic acid, glycine, cysteine and traces of
other amino acids (64).

However, synthetic complexes of these

molecules have been found to be less effective in lowering plasma
concentrations of glucose and triglycerides than the glucose
tolerance factor extracted from brewer's yeast (67).

Therefore,

adding inorganic chromium or even synthetic chromium complexes, as
above, to Y-79 cell medium, even in the presence of adequate
amounts of insulin, may not lead to enhanced growth (above that
caused by insulin alone).

Observation of the effect may have to

await purification and characterization of the glucose tolerance
factor.
The failure of selenium to enhance growth is also not
surprising because Y-79 cell stock cultures are maintained in
medium containing 3xlO”^M Na2Se03.

It probably takes far

longer than the length of our experiments (7 days) for cells to
become selenium depleted.

Indeed, in the one available case report

of a patient on total parenteral nutrition who developed selenium
deficiency, the patient did not become symptomatic until about two
years after beginning his course of hyperalimentation (31).

Also,

the in vitro studies of Rotruck et al. demonstrated that rat
erythrocytes only become abnormally susceptible to hemolysis 36-39
days after the rats begin receiving selenium deficient diets (52).
Several years ago, our lab did some preliminary experiments which
indicated that selenium enhanced the growth of Y-79 cells, and
since that time, Na2Se03 has been added to the stock medium in

-
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an optimum concentration of 3x10

—ft

Perhaps, the lack of

effect seen now is simply due to the longer time course necessary
to deplete the stock cells of already present selenoenzymes, such
as glutathione peroxidase (GSH-Px).

Another trial of selenium with

cells that had been grown in the absence of this metal for a more
prolonged period would be useful to both confirm selenium's ability
to enhance Y-79 cell growth as well as to elucidate the time course
necessary to deplete the cells of selenium.
The mechanism of the growth enhancing effect of transferrin
remains unclear.

Young et al. have noted a growth stimulating

effect of transferrin on SV3T3 cells at an optimum concentration of
10 °M but this effect is dependent on the presence of 100
ng/ml of biotin (71).

RPMI-1640 contains 200 ng/ml of biotin and

perhaps, the effect of transferrin on Y-79 cells is also biotin
dependent.

Young et al. postulate that this effect may be

secondary to unrelated metabolic events as their lab has also noted
that biotin lowers the level of lactate secreted by SV3T3 cells
(71).

It would be interesting to see if the growth enhancing

effect of transferrin on Y-79 cells is retained when biotin is
deleted from the medium.
We must also consider the possibility that Y-79 cells are
producing a growth factor(s) which interacts with transferrin to
provide a stimulus for cells to proliferate.

Similar factors have

been observed by Delarco and Todaro in transformed mouse cell lines
and they term these agents "sarcoma growth factors" (8).

This

hypothesis is attractive in light of the growth permissive effect
of medium, conditioned by Y-79 cells, on untransformed retinal
cells.

■
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The presence of transferrin receptors on the surfaces of human
lymphoblastoid and other malignant cell lines has been noted by
Galbraith et al. (13).

They hypothesize that transferrin

receptors are used by these cells to bind host protein and thereby
hide cell-specific antigens from the host immune system.

This

immunosurveillance theory is probably not an important
consideration under tissue culture conditions.

However, tumor

receptors for transferrin could still be important intermediaries
for transferrin's growth effect in vitro.

Therefore, a

demonstration of the presence of apotransferrin receptors on the
surface of Y-79 cells would certainly be of interest.
It is unlikely that the growth effect of transferrin can be
explained simply in terms of supplying the iron requirement of Y-79
cells since apotransferrin was used in all of our experiments.
However, it is possible that traces of iron salts contaminated our
transferrin preparation and provided Y-79 cells with a critical
element.

We are planning to assay our apotransferrin for the

presence of iron to help clarify this possibility.

It would also

be interesting to see if growth effects could be duplicated with
other organic iron compounds such as hemoglobin or transferrin from
other species, or even, inorganic iron salts.
Perhaps, transferrin plays a role in transporting other
crucial metallic cations besides iron.

The consistently greater

growth achieved by cells incubated in serum enriched medium
compared to cells grown in transferrin enriched medium might be
explained by the presence of these trace metals in serum.

Perhaps,

the growth enhancing effect of transferrin could be explained, and
indeed, increased to the levels achieved by cells grown in the

'
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presence of serum by adding certain trace metals to the medium.
Our studies were aimed at examining several likely candidates,
including copper, cobalt, chromium and selenium.
As shown in the results, copper, cobalt and chromium had no
significant effects on Y-79 cell growth.

These observations were

somewhat surprising since these three essential metals are all
known to bind to transferrin (23) and therefore, one might
conjecture that transferrin could increase their availability to
cells.

The unlikely possibility also exists that these metals,

required in trace amounts, are already present as contaminants in
saturating amounts, and therefore, no effect is seen with the
addition of even larger amounts.
The most intriguing observation of this study is the effect of
selenium and transferrin on the growth of Y-79 cells.

Although

transferrin alone had a small growth enhancing effect on Y-9 cells,
the addition of selenium and transferrin resulted in far greater
growth than that achieved by cells grown in transferrin alone.
explanation for this effect is unclear.

The

However, a related

observation comes from the work of Rodvien et al.

(51).

They

noted that rabbit erythrocyte GSH-Px activity was markedly
decreased by the induction of iron deficiency anemia whereas anemia
secondary to massive phlebotomy or administration of intraperitoneal phenylhydrazine did not lead to changes in enzyme
activity.

Also, during the induction of iron deficiency,

reticulocytes had lower enzyme activity than the older erythrocytes
while during the iron repletion phase, the opposite was observed.
Other enzymes, such as glutathione reductase, maintained constant
activities throughout the experiments.

They conjecture that iron
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may be necessary for the synthesis of GSH-Px or perhaps, that this
enzyme requires an iron containing protein as a coenzyme or
electron carrier.

Therefore, in our studies, transferrin may be

acting in an iron transport capacity, providing Y-79 cells with
enough iron to incorporate the available selenium into GSH-Px and
thus protect the cell membranes from oxidation.

However, as the

extent of selenium binding to transferrin is unknown, we cannot be
certain that transferrin does not play a more direct role.
Perhaps, it enables the cell to transport selenium more
efficiently, thereby making it more available for GSH-Px synthesis,
itself stimulated by the increased concentration of selenium (16).
While selenium alone enhances growth when added to Y-79 cells
which have been incubated in selenium deficient medium for a
prolonged period (past unpublished experiments), our current
experiments do not reveal a growth enhancing effect of selenium
when it is added alone to cells previously maintained in selenium
enriched medium.

Therefore, as discussed earlier, it is probable

that certain selenoproteins are not seriously depleted within one
week of incubation in selenium free medium.

However, the

enhancement of growth seen when cells are incubated in the presence
of selenium and apotransferrin occurs within several days of the
beginning of the experiment (Figures 15 and 16).

Therefore, it

remains unclear that this effect of selenium is, in fact,
dependent on its incorporation into selenoproteins.

Alternatively,

selenium could be incorporated into different selenoproteins in the
presence of apotransferrin.

Perhaps, transferrin increases

selenium's availability to Y-79 cells and/or its intracellular
concentration enabling them to synthesize other important

.
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selenoenzymes.

Of course, tranferrin, itself, acting as a growth

factor, could be directly responsible for activating a selenium
dependent system.

Further experiments should include observations

of the growth effect of apotransferrin in cells that have been
depleted of selenium over a prolonged period in order to ascertain
that transferrin is active alone as a growth promoting agent.
Also, elucidation of a connection between transferrin and selenium
systems will depend on further studies of transferrin and selenium
binding as well as GSH-Px activity in the Y-79 cell line.
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